The D.R.G. system in the minimally invasive treatment of varicocele. Our experience

1996 ◽  
Vol 63 (1_suppl) ◽  
pp. 75-77
Author(s):  
A. Valtorta ◽  
U. Mascini ◽  
G. Strada
Keyword(s):  
Surgical Treatment ◽  
Minimally Invasive ◽  
General Anaesthesia ◽  
Recurrence Rate ◽  
Patient Compliance ◽  
Local Anaesthesia ◽  
Minimally Invasive Treatment ◽  
Retroperitoneal Approach ◽  
Invasive Treatment ◽  
The Cost

This paper reports our experience in the surgical treatment of varicocele; 134 patients were operated upon, 78 with retroperitoneal approach under general anaesthesia and 56 with inguinal approach under local anaesthesia. We evaluated the patients’ compliance, the cost of the procedure, the frequency of complications and the recurrence rate. We strongly advise the inguinal approach as the procedure of choice because patient compliance is greater, recovery faster and the cost is lower. We are compelled, however, to keep the patient in hospital for two days because of the D.R.G. payment system.

scholarly journals Staged surgical treatment of the patient with chronic pancreatitis

2021 ◽  
Vol 26 (3) ◽  
pp. 149-155
Author(s):  
N. Yu. Kokhanenko ◽  
A. V. Glebova ◽  
O. G. Vavilova ◽  
A. A. Kashintsev ◽  
S. A. Kaliuzhnyi ◽  
...  
Keyword(s):  
Chronic Pancreatitis ◽  
Surgical Treatment ◽  
Minimally Invasive ◽  
Clinical Case ◽  
Minimally Invasive Treatment ◽  
Gastric Fistula ◽  
Invasive Treatment ◽  
Head Of The Pancreas ◽  
Staged Treatment

A clinical case of successful surgical treatment of a patient with chronic pancreatitis, complicated by suppuration of a postnecrotic cyst and the formation of a cysto-gastric fistula. As a result of the conservative and minimally invasive treatment, the pseudocyst was drained, and the cystogastric fistula was closed. The staged treatment was completed by resection of the head of the pancreas with the formation of an anastomosis.

scholarly journals Surgical treatment of recidivist lymphedema

Open Medicine ◽  
2016 ◽  
Vol 11 (1) ◽  
pp. 121-124
Author(s):  
Costantino Eretta ◽  
Alessia Ferrarese ◽  
Elisabetta Moggia ◽  
Elisa Francone ◽  
Carlo Sagnelli ◽  
...  
Keyword(s):  
Chronic Disease ◽  
Surgical Treatment ◽  
Minimally Invasive ◽  
Minimally Invasive Treatment ◽  
Invasive Treatment ◽  
The Past ◽  
Endoscopic Equipment ◽  
Laparoscopy Surgery ◽  
Advanced Laparoscopy

AbstractLymphedema is a chronic disease with a progressively ingravescent evolvement and an appearance of recurrent complications of acute lymphangitic type; in nature it is mostly erysipeloid and responsible for a further rapid increase in the volume and consistency of edema. The purpose of this work is to present our experience in the minimally invasive treatment for recurrence of lymphedema; adapting techniques performed in the past which included large fasciotomy with devastating results cosmetically; but these techniques have been proposed again by the use of endoscopic equipment borrowed from the advanced laparoscopy surgery, which allows a monoskin access of about one cm.

The glycemic profile of blood in people with diabetes mellitus, subjected to minimally invasive treatment of ureterolithiasis

2017 ◽  
pp. 71-77
Author(s):  
S.O. Vozianov ◽  
◽  
A.Yu. Gurzhenko ◽  
Keyword(s):  
Diabetes Mellitus ◽  
Surgical Treatment ◽  
Minimally Invasive ◽  
Glycosylated Hemoglobin ◽  
Upper Urinary Tract ◽  
Minimally Invasive Treatment ◽  
Invasive Treatment ◽  
Glucose Levels ◽  
Chronic Hyperglycemia ◽  
Glycemic Profile

The objective: to study the state of the glycemic profile in patients with ureterolithiasis and concomitant diabetes mellitus (DM) who underwent various methods of minimally invasive surgical treatment. Patients and methods. The study involved 204 people, 130 (63.7%) men and 74 (36.3%) women, the average age – 34.6±5.5 years. Subjects were divided into VI clinical groups: I – persons with diabetes and ureterolithiasis, who underwent TUСL and CS therapy per os (n=57); II – persons with DM and ureterolithiasis, who underwent TUСL without HS therapy (n=44); III – persons with DM and ureterolithiasis who were treated with ECU without HS therapy (n=32); IV – persons with ureterolithiasis without diabetes who underwent TUСL without HS therapy (n=41); V (control 1) – of the person with diabetes, who had an independent passage of stones from the ureter (n=18); VI (control 2) – healthy volunteers, with no signs of pathology (n=12). The diagnosis of ureterolithiasis was verified using clinico-anamnestic, laboratory and instrumental methods of investigation, according to the MHP protocols, before and after the disintegration of the stones by the method of transurethral contact lithotripsy (TUСL) and ESWL. Results. Elevated levels of HbA1c indicated chronic hyperglycemia for a long time, with the presence of violations of carbohydrate homeostasis and the need for its correction before and during surgery for ureterolithiasis. At this minimally invasive treatment of ureterolithiasis, the presence of an operational injury factor, with manifestations of permanent obstruction in the upper urinary tract (ESWL operation) did not contribute to a decrease in glucose levels in plasma and urine, unlike states with rapid elimination of acute calculous process (TUCL operation). Conclusion. Assistance to patients with diabetes mellitus, which is planned surgical treatment, allows to improve the condition of patients in the postoperative period and reduce the risk of postoperative сomplications. Key words: ureterolithiasis, diabetes mellitus, glycosylated hemoglobin, glucosuria, minimally invasive methods of lithotripsy.

scholarly journals Fuzheng Xiaoliu granules reduce the 2-year recurrence rate of early-stage hepatitis B virus-related hepatocellular carcinoma after comprehensive minimally invasive surgery: a study protocol for a prospective, multicenter, central randomized, double-blind, placebo-controlled clinical trial

2021 ◽  
Author(s):  
Xinju Chen ◽  
Suping Ma ◽  
Xiaoqi Chen ◽  
Yaokun Hao ◽  
Qing Zhao ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Minimally Invasive ◽  
Recurrence Rate ◽  
Early Stage ◽  
Minimally Invasive Treatment ◽  
Control Group ◽  
Invasive Treatment ◽  
B Virus

Abstract Background: Hepatitis B virus (HBV) infection is one of the most common risk factors for hepatocellular carcinoma (HCC). With the continuous improvement of minimally invasive treatment techniques such as transarterial chemoembolization (TACE) and radiofrequency ablation (RFA), comprehensive minimally invasive treatment (TACE & RFA) has been widely used in the treatment of early-stage (Barcelona Clinic Liver Cancer (BCLC) stage 0 and A) HCC and has good safety and clinical efficacy. However, recurrence and metastasis after comprehensive minimally invasive treatment are still key factors affecting the survival rate of patients. In recent years, Chinese medicine has highlighted its unique advantages in the adjuvant treatment of liver cancer surgery and minimally invasive treatment. Thus, this study aimed to evaluate the efficacy and safety of Fuzheng Xiaoliu granules (FZXLG) for treating early-stage HBV-related HCC after comprehensive minimally invasive treatment and to explore whether FZXLG can delay the progression of HBV-related HCC. Methods: This is a prospective, multicenter, central randomized, double-blind, placebo-controlled clinical trial. A total of 312 patients with early HBV-related HCC who underwent comprehensive minimally invasive treatment within 2 months were randomized in a 1:1 ratio into two groups: the experimental group and the control group. The experimental group will receive basic FZXLG plus Western medicine treatment, and the control group will receive basic FZXLG simulator plus Western medicine treatment. Each group will be treated for 1 year and followed-up for 1 year. The primary outcome measure is the 2-year recurrence rate of patients with early-stage HBV-related HCC after minimally invasive treatment. The secondary outcomes include (1) measurable active lesions, (2) alpha-fetoprotein (AFP), (3) immunological indicators, such as comparison of CD3+, CD4+, CD8+ absolute values, CD4+/CD8+ before and after the test, (4) hepatitis B virus quantity, and (5) Karnofsky functional status score. Discussion: These results will provide research data on the efficacy and safety of FZXLG for the treatment of early-stage HBV-related HCC after comprehensive minimally invasive treatment. These findings will also be based on laboratory indicators and adverse events for safety assessment to determine whether FZXLG can reduce the 2-year recurrence rate of HCC after minimally invasive surgery, which will provide reliable evidence for the clinical treatment of HCC.Trial registration: Chinese Clinical Trial Registry, ChiCTR1900022999. Registered on 5 May 2019.

scholarly journals EAU, AUA and NICE Guidelines on Surgical and Minimally Invasive Treatment of Benign Prostate Hyperplasia: A Critical Appraisal of the Guidelines Using the AGREE-II Tool

2021 ◽  
pp. 1-10
Author(s):  
Dmitry Enikeev ◽  
Vincent Misrai ◽  
Enrique Rijo ◽  
Roman Sukhanov ◽  
Denis Chinenov ◽  
...  
Keyword(s):  
Minimally Invasive ◽  
Treatment Options ◽  
Stakeholder Involvement ◽  
Minimally Invasive Treatment ◽  
Invasive Treatment ◽  
Agree Ii ◽  
Prostate Hyperplasia ◽  
Assessment Score ◽  
Nice Guideline ◽  
Agree Ii Tool

<b><i>Objective:</i></b> To critically appraise the methodological rigour of the clinical practice guidelines (CPGs) vis-à-vis BPH surgery as used by specialist research associations in the US, Europe and UK, and to compare whether the guidelines cover all or only some of the available treatments. <b><i>Methods:</i></b> The current guidelines issued by the EUA, AUA and NICE associations have been analyzed by 4 appraisers using the AGREE-II instrument. We also compared the recommendations given in the guidelines for surgical and minimally invasive treatment to find out which of these CPGs include most of the available treatment options. <b><i>Results:</i></b> According to the AGREE II tool, the median scores of domains were: domain 1 scope and purpose 66.7%, domain 2 stakeholder involvement 50.0%, domain 3 rigor of development 65.1%, domain 4 clarity of presentation 80.6%, domain 5 applicability 33.3%, domain 6 editorial independence 72.9%. The overall assessment according to AGREE II is 83.3%. The NICE guideline scored highest on 5 out of 6 domains and the highest overall assessment score (91.6%). The EAU guideline scored lowest on 4 out of 6 domains and has the lowest overall assessment score (79.1%). <b><i>Conclusions:</i></b> The analyzed CPGs comprehensively highlight the minimally invasive and surgical treatment options for BPH. According to the AGREE II tool, the domains for clarity of presentation and editorial independence received the highest scores. The stakeholder involvement and applicability domains were ranked as the lowest. Improving the CPG in these domains may help to improve the clinical utility and applicability of CPGs.

Sign in / Sign up

Export Citation Format

Share Document